Britain has received experimental favipiravir from Japan to support its response to a hantavirus outbreak linked to a cruise ship, though the drug has no established protocol or proven efficacy for treating the virus.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 1 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
primary treatment remains rest and fluids
Britain gets experimental drug from Japan to bolster hantavirus responseSpotted something wrong on this page? Report a correction.